Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate
Authors:
- Stefano IacobelliSIStefano Iacobelli
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer
- Vol. 29 (9) , 1280-1284
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancerCancer, 1992
- Phase I Trial of 5-Day Continuous Venous Infusion of Oxaliplatin at Circadian Rhythm-Modulated Rate Compared With Constant RateJNCI: Journal of the National Cancer Institute, 1990
- Phase I study of oxaliplatin in patients with advanced cancerCancer Chemotherapy and Pharmacology, 1990
- A Phase II Study of Carboplatin and CHIP in Patients with Metastatic Colon CarcinomaAmerican Journal of Clinical Oncology, 1989
- Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinumBiomedicine & Pharmacotherapy, 1989
- Circadian time dependence of murine tolerance for carboplatinToxicology and Applied Pharmacology, 1988
- CBDCAAmerican Journal of Clinical Oncology, 1987
- Antitumor activity of l-OHP in miceCancer Letters, 1985
- Circadian Timing of Cancer ChemotherapyScience, 1985
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958